For CRC187, the final tumor masses of KLF14‐shRNA1, KLF14‐shRNA2, EGR2‐shRNA1, and EGR2‐shRNA2 were 2.84‐, 2.18‐, 2.87‐, and 1.90‐fold higher than control PDOX, respectively (Figure 3G). Here, KLF14 is linked to neoplasm.